{"id":44966,"date":"2022-06-10T17:01:49","date_gmt":"2022-06-10T15:01:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/"},"modified":"2022-06-10T17:01:49","modified_gmt":"2022-06-10T15:01:49","slug":"onward-announces-results-of-annual-general-meeting-of-shareholders","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/","title":{"rendered":"ONWARD Announces Results of Annual General Meeting of Shareholders"},"content":{"rendered":"
\n

\nShareholders approval all resolutions on the agenda<\/i>\n<\/p>\n

EINDHOVEN, the Netherlands & LAUSANNE, Switzerland–(BUSINESS WIRE)–THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596\/2014).<\/b>\n<\/p>\n

<\/a><\/p>\n

\nONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injury, today announces all proposed resolutions at its Annual General Meeting of Shareholders (AGM), held this morning in Amsterdam, the Netherlands at 10.00a CEST, were duly passed. The full details of the resolutions approved during the AGM can be found on ONWARD\u2019s Investor Relations website<\/a>.\n<\/p>\n

\nTo learn more about ONWARD\u2019s ARC Therapy and the company\u2019s vision to restore movement, independence and health in people with spinal cord injury, please visit ONWD.com<\/a>.\n<\/p>\n

\nAbout ONWARD<\/b>\n<\/p>\n

\nONWARD is a medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord injuries. ONWARD\u2019s work builds on more than a decade of basic science and preclinical research conducted at the world\u2019s leading neuroscience laboratories. ONWARD\u2019s ARC Therapy, which can be delivered by implantable (ARCIM<\/sup>) or external (ARCEX<\/sup>) systems, is designed to deliver targeted, programmed spinal-cord stimulation to restore movement and other functions in people with spinal cord injury, ultimately improving their quality of life. ONWARD has received three Breakthrough Device Designations from the FDA encompassing both ARCIM <\/sup>and ARCEX<\/sup>. The company\u2019s first FDA pivotal trial, called Up-LIFT, completed enrollment in December 2021 with 65 subjects worldwide. The company completed first-in-human use of its ARCIM<\/sup> neurostimulator in May 2022.\n<\/p>\n

\nONWARD is headquartered at the High Tech Campus in Eindhoven, the Netherlands. It maintains an office in Lausanne, Switzerland and has a growing U.S. presence in Boston, Massachusetts, USA. For additional information about the company, please visit ONWD.com<\/a>. To access our 2022 Financial Calendar, please visit IR.ONWD.com<\/a>.\n<\/p>\n

\nDisclaimer<\/b>\n<\/p>\n

\nCertain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company or, as appropriate, the Company directors\u2019 current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person\u2019s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor Company Enquiries:
\n
info@onwd.com<\/a><\/p>\n

For Media Enquiries:
\n
Andy Dolan
\n
media@onwd.com<\/a>
+1.508.649.8466<\/p>\n

For Investor Enquiries:
\n
investors@onwd.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Shareholders approval all resolutions on the agenda EINDHOVEN, the Netherlands & LAUSANNE, Switzerland–(BUSINESS WIRE)–THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596\/2014). ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44966","6":"format-standard","7":"category-industry"},"yoast_head":"\nONWARD Announces Results of Annual General Meeting of Shareholders - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ONWARD Announces Results of Annual General Meeting of Shareholders - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Shareholders approval all resolutions on the agenda EINDHOVEN, the Netherlands & LAUSANNE, Switzerland–(BUSINESS WIRE)–THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596\/2014). ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-10T15:01:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220610005300\/en\/1428542\/21\/ONWARD_Logotype%E2%84%A2_Red.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ONWARD Announces Results of Annual General Meeting of Shareholders\",\"datePublished\":\"2022-06-10T15:01:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/\"},\"wordCount\":610,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005300\\\/en\\\/1428542\\\/21\\\/ONWARD_Logotype%E2%84%A2_Red.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/\",\"name\":\"ONWARD Announces Results of Annual General Meeting of Shareholders - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005300\\\/en\\\/1428542\\\/21\\\/ONWARD_Logotype%E2%84%A2_Red.jpg\",\"datePublished\":\"2022-06-10T15:01:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005300\\\/en\\\/1428542\\\/21\\\/ONWARD_Logotype%E2%84%A2_Red.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220610005300\\\/en\\\/1428542\\\/21\\\/ONWARD_Logotype%E2%84%A2_Red.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/onward-announces-results-of-annual-general-meeting-of-shareholders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONWARD Announces Results of Annual General Meeting of Shareholders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ONWARD Announces Results of Annual General Meeting of Shareholders - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/","og_locale":"en_US","og_type":"article","og_title":"ONWARD Announces Results of Annual General Meeting of Shareholders - Pharma Trend","og_description":"Shareholders approval all resolutions on the agenda EINDHOVEN, the Netherlands & LAUSANNE, Switzerland–(BUSINESS WIRE)–THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596\/2014). ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence, and health in people with spinal cord ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-10T15:01:49+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220610005300\/en\/1428542\/21\/ONWARD_Logotype%E2%84%A2_Red.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ONWARD Announces Results of Annual General Meeting of Shareholders","datePublished":"2022-06-10T15:01:49+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/"},"wordCount":610,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220610005300\/en\/1428542\/21\/ONWARD_Logotype%E2%84%A2_Red.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/","url":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/","name":"ONWARD Announces Results of Annual General Meeting of Shareholders - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220610005300\/en\/1428542\/21\/ONWARD_Logotype%E2%84%A2_Red.jpg","datePublished":"2022-06-10T15:01:49+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220610005300\/en\/1428542\/21\/ONWARD_Logotype%E2%84%A2_Red.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220610005300\/en\/1428542\/21\/ONWARD_Logotype%E2%84%A2_Red.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/onward-announces-results-of-annual-general-meeting-of-shareholders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ONWARD Announces Results of Annual General Meeting of Shareholders"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44966"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44966\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}